Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 5
2014 7
2015 2
2016 3
2017 3
2018 1
2019 4
2020 1
2021 3
2022 1
2023 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy.
Absolom K, Warrington L, Hudson E, Hewison J, Morris C, Holch P, Carter R, Gibson A, Holmes M, Clayton B, Rogers Z, McParland L, Conner M, Glidewell L, Woroncow B, Dawkins B, Dickinson S, Hulme C, Brown J, Velikova G. Absolom K, et al. J Clin Oncol. 2021 Mar 1;39(7):734-747. doi: 10.1200/JCO.20.02015. Epub 2021 Jan 8. J Clin Oncol. 2021. PMID: 33417506 Free article. Clinical Trial.
The REQUITE project: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in cancer survivors.
West C, Azria D, Chang-Claude J, Davidson S, Lambin P, Rosenstein B, De Ruysscher D, Talbot C, Thierens H, Valdagni R, Vega A, Yuille M. West C, et al. Clin Oncol (R Coll Radiol). 2014 Dec;26(12):739-42. doi: 10.1016/j.clon.2014.09.008. Epub 2014 Sep 27. Clin Oncol (R Coll Radiol). 2014. PMID: 25267305 No abstract available.
Acute and Late Adverse Events Associated With Radical Radiation Therapy Prostate Cancer Treatment: A Systematic Review of Clinician and Patient Toxicity Reporting in Randomized Controlled Trials.
Holch P, Henry AM, Davidson S, Gilbert A, Routledge J, Shearsmith L, Franks K, Ingleson E, Albutt A, Velikova G. Holch P, et al. Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):495-510. doi: 10.1016/j.ijrobp.2016.11.008. Epub 2016 Nov 18. Int J Radiat Oncol Biol Phys. 2017. PMID: 28126299 Free article. Review.
Reply to H. Shojima et al.
Absolom K, Warrington L, Hudson E, Hewison J, Holch P, Dawkins B, Hulme C, Brown J, Velikova G. Absolom K, et al. J Clin Oncol. 2021 Aug 10;39(23):2633-2634. doi: 10.1200/JCO.21.00684. Epub 2021 May 12. J Clin Oncol. 2021. PMID: 33979207 Free PMC article. No abstract available.
ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research.
Reeve BB, Wyrwich KW, Wu AW, Velikova G, Terwee CB, Snyder CF, Schwartz C, Revicki DA, Moinpour CM, McLeod LD, Lyons JC, Lenderking WR, Hinds PS, Hays RD, Greenhalgh J, Gershon R, Feeny D, Fayers PM, Cella D, Brundage M, Ahmed S, Aaronson NK, Butt Z. Reeve BB, et al. Qual Life Res. 2013 Oct;22(8):1889-905. doi: 10.1007/s11136-012-0344-y. Epub 2013 Jan 4. Qual Life Res. 2013. PMID: 23288613 Review.
Patient-reported outcomes in randomised controlled trials of gynaecological cancers: investigating methodological quality and impact on clinical decision-making.
Efficace F, Jacobs M, Pusic A, Greimel E, Piciocchi A, Kieffer JM, Gilbert A, Fayers P, Blazeby J; EORTC Quality of Life Group Patient Reported Outcome Measurements Over Time In ONcology-PROMOTION Registry. Efficace F, et al. Eur J Cancer. 2014 Jul;50(11):1925-41. doi: 10.1016/j.ejca.2014.04.005. Epub 2014 May 10. Eur J Cancer. 2014. PMID: 24825114 Free article. Review.
26 results